Study to Evaluate the Efficacy and Safety of Larazotide Acetate for the Relief of CeD Symptoms

Inclusion Criteria: * Male and female adults diagnosed with celiac disease (positive celiac serology plus confirmed biopsy) for at least 6 months * On a gluten-free diet for at least 6 months * Experiencing symptoms (ie, abdominal pain, abdominal cramping, bloating, gas, diarrhea, loose stool, or nausea) * Willing to maintain current gluten-free diet throughout participation in the study Exclusion Criteria: * Refractory celiac disease or severe complications of celiac disease * Chronic active GI disease other than celiac disease